about
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.Beta-endorphin 1-31 biotransformation and cAMP modulation in inflammationOpioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.MOR1 expression in gastric cancer: a biomarker associated with poor outcome.The role of morphine in regulation of cancer cell growth.Antitumor activity of opiorphin, sialorphin and their conjugates with a peptide klaklakklaklak.Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro.Endogenous μ-opioid peptides modulate immune response towards malignant melanoma.Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line.Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging.Binding of endomorphin-2 to mu-opioid receptors in experimental mouse mammary adenocarcinoma.Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells.Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth.
P2860
Q33925013-ABB92E85-53D4-4E7B-A494-4CB85BF2530FQ35117580-BB0396AF-1830-480F-B6DC-45AEBF295A50Q35598669-FD41514A-9E59-4895-815D-215BDA32A178Q37075319-364E130F-1336-4ADE-BA82-11D5977C9290Q37700635-0BD52E2F-6948-4DA2-9A30-526870774B08Q37907914-3E60DA7F-6104-4938-B8AF-CC5B3501425EQ38730361-04F295AE-A82A-4389-8DF2-3E5EC7F7C05FQ39034167-34E918B7-C9C2-4144-9031-0FBCA6F44941Q39039268-19650F9D-34EF-4B92-97BD-E1E7A6F568B4Q39826592-6DF0A56F-A948-4585-BD84-109889C5B9BAQ39975543-A5435FF9-04AD-4772-BFAF-FEFCE756D43BQ41460733-A6F23E25-E7B6-4F1C-B2BC-87A3CA456D81Q42120324-12D11B00-9AF1-48B5-B68E-6ECA0D8A1C1CQ44348596-FBFBE66A-835E-403C-8D3A-E2A3A8F02191Q46955479-34E2E400-03BF-4B05-ABF2-318DCF2E3CA0Q48151505-2E75E1D6-D6D9-45BE-90FA-A8847B98FB34
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Opioid peptides in cancer.
@ast
Opioid peptides in cancer.
@en
type
label
Opioid peptides in cancer.
@ast
Opioid peptides in cancer.
@en
prefLabel
Opioid peptides in cancer.
@ast
Opioid peptides in cancer.
@en
P1476
Opioid peptides in cancer.
@en
P2093
Anna Janecka
P304
P356
10.1023/B:CANC.0000031773.46458.63
P50
P577
2004-08-01T00:00:00Z
P6179
1002133857